Liu, Yusi. “How Do Varying Concentrations and Treatment Durations of Anti-PDL1 Antibodies Affect HCT116 Cell Viability, Xenograft Tumor Size, and T Cell Activation, As Measured by MTT Assay, Tumor Weight, and IL-2 Production, Respectively?”. MedScien, vol. 2, no. 6, Dec. 2024, p. 2912, doi:10.61173/n49rc157.